Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TEAD1 | P28347 | 3/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.30 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.30 |
| ▸ | PRKCG | P05129 | 1/20 | 0.30 |
| ▸ | PRKCB | P05771 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | PRKCH | P24723 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.30 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25864015 | 1.00 | RAB9A (0.32) | RAB9ATEAD1CETPKDM4EALDH1A1 | |
| SCHEMBL24102949 | 0.90 | RAB9A (0.38) | RAB9ACETPKDM4EALDH1A1P2RY1 | |
| SCHEMBL25865691 | 0.82 | RAB9A (0.33) | RAB9ATEAD1CETPKDM4EALDH1A1 | |
| SCHEMBL29162379 | 0.80 | RAB9A (0.39) | RAB9AP2RY1 | |
| SCHEMBL24103432 | 0.80 | RAB9A (0.39) | RAB9AP2RY1 | |
| SCHEMBL30324813 | 0.80 | RAB9A (0.39) | RAB9AP2RY1 | |
| SCHEMBL24053538 | 0.77 | RAB9A (0.40) | RAB9ACETPKDM4EALDH1A1P2RY1 | |
| SCHEMBL22116201 | 0.76 | P2RY1 (0.34) | RAB9AKDM4EALDH1A1P2RY1 | |
| SCHEMBL22116206 | 0.76 | P2RY1 (0.34) | RAB9AKDM4EALDH1A1P2RY1 | |
| SCHEMBL24053537 | 0.73 | RAB9A (0.41) | RAB9ATEAD1CETPKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234945-A1 | AZABICYCLYL-SUBSTITUTED HETEROCYCLES AS FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234945-A1 | AZABICYCLYL-SUBSTITUTED HETEROCYCLES AS FUNGICIDES | CYP1B1, DDT, CYP1A1 | RAB9A 1235/4885TEAD1 2685/4885CETP 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.